Cargando…
The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway
Ciclopirox olamine (CPX), an off-patent antifungal agent used to treat mycoses of skin and nails, has recently been demonstrated to be a potential anticancer agent. However, the underlying mechanism is not well understood. Here for the first time we show that CPX inhibited lymphangiogenesis in an in...
Autores principales: | Luo, Yan, Zhou, Hongyu, Liu, Lei, Shen, Tao, Chen, Wenxing, Xu, Baoshan, Han, Xiuzhen, Zhang, Fangfang, Scott, Rona S., Alexander, J. Steven, Alam, Antoine, Huang, Shile |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088775/ https://www.ncbi.nlm.nih.gov/pubmed/21217783 http://dx.doi.org/10.1038/onc.2010.590 |
Ejemplares similares
-
Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A
por: Shen, Tao, et al.
Publicado: (2017) -
Ciclopirox activates ATR-Chk1 signaling pathway leading to Cdc25A protein degradation
por: Shen, Tao, et al.
Publicado: (2018) -
Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway
por: Zhou, Hongyu, et al.
Publicado: (2014) -
HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3
por: Han, Tao, et al.
Publicado: (2018) -
HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3
por: Han, Tao, et al.
Publicado: (2022)